Next Article in Journal
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review
Previous Article in Journal
Purification of a Multidrug Resistance Transporter for Crystallization Studies
Previous Article in Special Issue
NETs and CF Lung Disease: Current Status and Future Prospects
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 4
Issue 2
10.3390/antibiotics4020136
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Host Defense Peptides from Asian Frogs as Potential Clinical Therapies

by
Vineeth T.V. Kumar
1,
David Holthausen
2,
Joshy Jacob
2,* and
Sanil George
1,*
1
Molecular Ecology Lab, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram, Kerala 695014, India
2
Emory Vaccine Center, Department of Microbiology and Immunology, Emory University, Yerkes National Primate Research Center, 954 Gatewood Rd, Atlanta, GA 30329, USA
*
Authors to whom correspondence should be addressed.
Antibiotics 2015, 4(2), 136-159; https://doi.org/10.3390/antibiotics4020136
Submission received: 10 November 2014 / Revised: 28 February 2015 / Accepted: 4 March 2015 / Published: 30 March 2015
(This article belongs to the Special Issue Antimicrobial Peptides)
Browse Figures
Versions Notes

Abstract

:
Host defense peptides (HDPs) are currently major focal points of medical research as infectious microbes are gaining resistance to existing drugs. They are effective against multi-drug resistant pathogens due to their unique primary target, biological membranes, and their peculiar mode of action. Even though HDPs from 60 Asian frog species belonging to 15 genera have been characterized, research into these peptides is at a very early stage. The purpose of this review is to showcase the status of peptide research in Asia. Here we provide a summary of HDPs from Asian frogs.

1. Introduction

The origins of the study into host defense peptides began with the pioneering studies of Vittorio Erspamer, who discovered biogenic amines and peptides secreted by the amphibian skin. The field later diversified when Zasloff isolated magainin from Xenopus laevis [1,2]. In our current era of multi-drug resistant bacterial strains, discovering new and effective treatments to replace traditional antibiotics is a critical area of research. Host defense peptides (HDPs), such as those being found in the skin of Asian frogs, have shown effectiveness in killing both gram-negative and gram-positive bacteria, as well as some viruses and cancers, without any of the drawbacks of antibiotic resistance [3]. These properties make them viable candidates as the next wave of therapies against infectious and non-infectious diseases that are the leading cause of death in developing countries.
Research on how these anti-microbial peptides function is still in the early stages. Most of the HDPs are typically cationic, a feature which allows them to interact with the negatively charged bacterial and cancer cell membranes. This cationic nature allows some peptides to actually penetrate the surface of pathogens as a means of killing them [4]. Asia is well known for its diverse amphibian populations and has been a resource for novel HDPs. Recently, potent HDPs have been isolated from amphibians located in temperate regions (traditionally believed to have low biodiversity) and have proven to be efficient in combating many clinical pathogens, though research into these peptides is still at a very early stage. We hope as we continue to discover new peptides in this region we will also find more potential candidates for novel therapeutics.

2. Diversity of HDPs Found in the Skin Secretion of Asian Frogs

In the tropics, especially in the rain forests of Asia, effective host defense peptides have helped the frogs to survive within their environment and attain a rich diversity. However with the alarming rate of decline in amphibians globally, many identified and unidentified species have become extinct before researchers ever had a chance to isolate their HDPs for study [5]. Those peptides that have been isolated show a great degree of variability—even within a single genus, different species produce varied repertoires. These differences can be correlated to habitat specific challenges endured by each species, and how these frogs uniquely evolved alongside their environment [6]. Even within the same frog, expression of several members of a particular family of HDP is observed. The variation in these peptide sequences is suggestive evidence for ancestral gene duplication [7]. No two peptides with identical amino acid sequences have been reported even from closely related species. Such diversity provides broad-spectrum protection against the large pool of microbes/predators in their habitat (Figure A1, Figure A2, Figure A3 and Figure A4) [8]. Transcriptomic and peptidomic analysis revealed that genera will have HDP families in common, apart from this, some unique peptides, such as neuroendocrine and smooth muscle active, are reported that serve a particular purpose in that habitat e.g., bradykinin related peptides (BRPs) and Trypsin inhibitors from Odorrana genus. Here we review the HDP families reported from Asian frogs. Despite the wealth of biodiversity, attempts to characterize HDPs from Asian frogs have been limited. In the present medical scenario there is an urgent need to uncover the hidden peptides that may lead to developing new and potentially crucial therapeutic agents.

2.1. Amolops

Genus Amolops, which belongs to the family Ranidae, is endemic to China. Eight species of frogs from this genus have been studied and their HDPs isolated (Table 1 and Table 2). The most common peptides isolated are of the Brevenin 1 and 2, Esculentin 2, Palustrin 2, and Temporin families, and all of them have been shown to be active against gram-positive and -negative bacteria, fungi, and cancer cells [9,10,11,12,13,14]. Cytotoxicity analysis against K562 and HT29 of Palustrin 2 from A. jindongensis skin revealed IC50 values between 57–58 µM [11].
Table
Table 1. List of peptides identified from the skin secretion of Asian frogs.
Table 1. List of peptides identified from the skin secretion of Asian frogs.
Peptides isolated from the respective frog species: numbers indicate paralogs of each peptide family
Genus: AmolopsBrevinin-1Brevinin-2Esculentin-2Palustrin-2TemporinNovel family of PeptidesRef
1A. chunganensis5 1 1 1 5 [9,10,11,12,13,14,15,16,17]
2A. hainanensis 2 1 Amylopin-1: 3 Amylopin-6: 1 Hainanenin 1-5,5 families: 5
3A. jindongenensis1 2 2 Jindongnenin: 1
4A. loloensis4 2 11 Amylopin 1-2,2 families: 2 Amylopkinin: 1
5A. lifanensis3 1
6A. ricketti3 2
7A. torrentis 1
8A. wuyiensis Amylopkinin: 2
Genus: GlandiranaBrevinin-1Brevinin-2Esculentin-2 Ref
1G. rugosa2 (Gaegurin 5–6)6 (Gaegurin 1–3 Rugosin A,B,C) [13,18,19,20]
2G. emeljanovi2 (Gaegurin 5–6) 1 (Gaegurin 5–6)
Genus: HylaranaBrevinin-1Brevinin-2Esculentin-1Esculentin-2TemporinNovel family of PeptidesRef
1H. erythrea32 41 [8,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36]
2H. guentheri26 6Guentherin: 1 Bradykinin BRP: 12 *
3H. latuouchii43226Palustrin-2
4H. luctiosa 4112Palustrin-2: 2
5H. nigrovittata7 (7 Gaegurins)9 (9 Rugosins) 3Nigroain: 15 Ranakinin N: 1 Cholycytokinin: 1
6H. picturata2 5 1
7H. signata5 4 2Palustrin-2
8H. spinulosa2 4 125Spinulosain: 1 Ranatuerin: 1 Nigroain: 5 Odorranain: 1 Ranacyclin: 1
9H. temporalis1 2 3 Hylaranakinin: 2
Genus: Odorrana Brevinin-1Brevinin-2Esculentin-1Esculentin-2Nigrocin-2Novel family of PeptidesRef
1O. grahamii24244Takykinin: 2 TrypsinInhibitor: 1, BRP: 3 * BLP: 5 * Odorrnalectin: 1 Palustrin-2: 1
Grahamin 1–2: 2 families: 2 Odorranain: 27 		[14,28,31,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58]
2O. hananensis22 Odorrnain: 2 Temporin: 2
3O. hejiangensis TrypsinInhibitor: 1
4O. hossi22112
5O. ishikawae13215Ishikawain 1–8, 8 families: 8 Palustrin 2: 3 Odorranain: 2
6O. jingdongensis31 22
7O. livida Lividin 1–4, 4 families: 4
8O. schmakeri3311 BRP: 7 *
9O. tiannanensis3 121Mararetaein: 2 Pleurain: 1 Tiannenensin: 1 Odorranain: 10
10O. versablis2 22 Ranatuerins: 2 Temporin: 1 TrypsinInhibitor: 1
Genus: PelophylaxBrevinin-1Brevinin-2Esculentin-1Esculentin-2Novel family of PeptidesRef
1P. plancyi 3 [13,20,56,59,60]
2P. porosus 1
3P. chosenicus 1
4P. fukienensis1 11Pelophylaxin 1–4, 4 families Ranakinestatin: 1
5P. nigromaculata 1 (Nigrocin-1)2 Nigocin-2: 1
Genus: Rana Brevinin-1Brevinin-2Temporin-1Ranatuerin-2Novel family of PeptidesRef
1R. amurensis3 (Amurin 1–3:3 families) 2 [20,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80]
2R brevipoda porsa11
3R. chaochioensis Japonicin-2: 4
4R. chensinensis6311 RCSK 1–4, 4 families: 4 * Chensinin 1–4, 4 families: 7 Japonicin-1: 1 D-1CDYa: 1 **
5R. dybowskii18 (9 Dybowskins)73 Japonicin-1: 1
6R. japonica 1 Japonicin-1: 1 Japonicin-2: 1
7R. okinavana4 1
8R. ornativentris 274Palustrin: 1
9R. pirica1521
10R. pleuradan Pleurain: 2
11R. sakurai 241MRP: 1 *, BRP: 1 *
12R. shuchinae Shuchin 1–5, 5 families: 5
13R. tagoi1 1 MRP: 1 *
14R. tagoiokiensis2 22
15R. tsushimensis114
Genus: Clinotarsus Ref
1C. curtipesBrevinin-1: 5 [81]
Genus: Fejervaria
1F. carcrivoraTigerinin: 2 [82]
Genus: Hoplobatracus
1H. rugulosusTigerinin-1: 1 [83,84,85]
2H. tigerinusTigerinin 1–4, 4 families: 4
Genus: Hyla Ref
1H. annectansAnnotoxin: 1 [86]
Genus: Limnonectes
1L. fujianensisLimnonectins: 2 [87]
Genus: Nanorana
1N. parkeriJaponicin: 2 Parkerin: 1 [88]
Genus: Rhacophorus
1R. duboisiPolypedarelaxin: 1 Polypedatein: 1 [89,90]
2R. schegliiHistone 2B
Genus: Sanguirana
1S. variansBLP: 1 * [91]
Genus: Euphlyctis
1E. hexadactylusCrude skin extract: peptidesnot characterized [92]
* Abbreviations used in the table: BRP—Bradykinin like peptide, BLP—Bombesisn like peptide, RCSK—R. chensinensis skin kinogen, MRP—Mellitin related peptide. Paralogs: Peptides of a particular family with little sequence homology found within a species, Orthologs: Particular family of peptides found withi two different species or genuses. ** CDY in the peptide D-1CDYa was used to indicate that the peptides were obtained from Chinese frog (C) found in Dongbei Region (D, northeast), city of Xifeng (Y).
Table
Table 2. List of peptides identified from the skin secretion of Asian frogs with their corresponding MIC and IC50/LD50 values.
Table 2. List of peptides identified from the skin secretion of Asian frogs with their corresponding MIC and IC50/LD50 values.
MIC and IC50/LD50 values
Genus: AmolopsBrevinin-1Brevinin-2Esculentin-2Palustrin-2TemporinNovel family of Peptides
1 A. chunganensisG+: 0.5–75 µM G−: 4–150 µM F: 4–150 µM LD50: 15–150 µM G+: 2–75 µM G−: 2–150 µM F: 9 µM LD50: 75 µM G+: 1–19 µM G−: 75–150 µM F: 4.5 µM LD50: 75 µM G+: 2–150 µM G−: 4–10 µM F: 4.5 µM LD50: 75 µMG+: 4–150 µM G−: 75 µM F: 9–150 µM LD50: 150–200 µM
2 A. hainanensis Unknown Unknown Amylopins: G+: 37–75 µg/mL G−: no active Hainanenin: G+: 4–40 µM G−: 4–75 µM F: 2–75 µM
3 A. jindongenensisUnknown Unknown G+: 20 µM G−: 13–50 µM F: not active IC50: 57–58 µM (K562 & HT29 cell lines) Jindongnenin:G+: 17–60 µM G−: 10–40 µM F: 60 µM
4 A. loloensisG+: 5 µg/mL G−: 2–7 µg/mL F: not active IC50: 58 µg/mL (HepG2 cell line) G+: 1–8 µg/mL G−: 7–50 µg/mL F: 2–22 µg/mL G+: 1–75 µg/mL G−: 1–75 µg/mL F: 1–25 µg/mL IC50: 77 µg/mL (HepG2 cell line)Amylopin: G+: 37–75 µg/mL G−: no active Amylopkinin: Smooth muscle active peptide
5 A. lifanensisUnknown Unknown
6 A. rickettiG+: 3–25 µg/mL G−: 12.5 µg/mL F: 100–200 µg/mL LD50: 100–200 µg/mL G+: 1–200 µg/mL G−: 6–15 µg/mL F: 200 µg/mL
7 A. torrentis Unknown
8 A. wuyiensis Amylopkinin: Smooth muscle active peptide
Genus: GlandiranaBrevinin-1Brevinin-2Esculentin-2
1 G. rugosaUnknown G+: 6–50 µg/mL G−: 12.5–100 µg/mL
2 G. emeljanoviUnknown Unknown
Genus: HylaranaBrevinin-1Brevinin-2Esculentin-1Esculentin-2TemporinNovel family of Peptides
1H. erythreaUnknownG+: 12.5 µM G−: 12.5 µM F: 50 µM LD50: 280 µM UnknownUnknown
2H. guentheriUnknownG+: 3–6 µM G−: 2–6 µM F: not active LD50: 280 µM G+: 30–50 µM G−: not active F: not activeGuentherin G+: 33.5 µg/mL Bradykinin, BRP: smooth muscle active peptide
3H. latuouchiiG+: 6–10 µg/mL G−: 12.5 µg/mL F: 100–200 µg/mL LD50: 100–200 µg/mLG+: 0.5–8 µg/mL G−: 0.5–130 µg/mL F: not active LD50: 400–600 µg/mLG+: 0.6–10 µg/mL G−: 0.6–10 µg/mL F: 80 µg/mL LD50: 500 µg/mLG+: 30–60 µg/mL
G−: 6–15 µg/mL F: not active LD50: 500 µg/mL		G+: 6–10 µg/mL G−: not active
F: not active LD50: 40 µg/mL		Palustrin: G+: 1–14 µg/mL
G−: not active F: not active LD50: 220 µg/mL
4H. luctiosa UnknownUnknownG+: 4 µM G−: 32 µMG+: 32 µM G−: 128 µMPalustrin: G+: 1–14 µg/mL G−: not active F: not active LD50: 220 µg/mL
5H. nigrovittataG+: 1–65 µg/mL G−: 18–40 µg/mL F: 2–5 µg/mLG+: 4–20 µg/mL G−: 25–100 µg/mL F: 5–20 µg/mL G+: 3–9 µg/mL G−: 4–15 µg/mL F: 3–9 µg/mLNigroain:G+: 9–50 µg/mL G−: 25–110 µg/mL F: 2–4 µg/mL Ranakinin N, Cholycytokinin: smooth muscle active peptides
6H. picturataG+: 3 µM G−: 24 µMG+: 9–18 µM G−: 9–72 µM Unknown
7H. signataUnknownUnknown UnknownPalustrin G+: 1–14 µM
8H. spinulosaG+: 3–100 µM G−: 100–400 µM F: 12.5 µMG+: 3–200 µM G−: 3–400 µM F: 100–400 µMUnknownG+: 6–200 µM G−: 12–400 µM F: not activeG+: 6–25 µM G−: not active F: 100–400 µMSpinulosain,Ranatuerin,Nigroain,Odorranain, Ranacyclin:Unknown
9H. temporalisG+: 100–150 µg/mL G−: 30–150 µg/mLG+: 40–150 µg/mL G−: 20–150 µg/mL Unknown Hylaranakinin:Unknown
Genus: OdorranaBrevinin-1Brevinin-2Esculentin-1Esculentin-2Nigrocin-2Novel family of Peptides
1 O. grahamiiUnknown Unknown Unknown Unknown G+: 9–100 µg/mL G−: 4–100 µg/mL F: 1–10 µg/mL Takykinin,TrypsinInhibitor, BRP,BLP: smooth muscle active peptides Odorrnalectin: drug targeting Grahamin: G+: 2.5 µg/mL G−: 1–8 µg/mL F: 7.5 µg/mL Palustrin: G+: 12–100 µM G−: 100 µM F: 100 µM Odorranain: G+: 2–90 µg/mL G−: 3–50 µg/mL F: 1–50 µg/mL
2 O. hananensisG+: 1–150 µM G−: 9–150 µM F: 1–10 µM LD50: 75 µM G+: 9–150 µM G−: 9–10 µM F: 19–40 µM LD50: 300 µM Odorranain: Unknown Temporin: G+: 2–150 µM G−: 30–75 µM F: 9–75 µM LD50: 75–300 µM
3 O. hejiangensis Trypsin Inhibitor: smooth muscle active peptide
4O. hossiG+: 3 µM G−: 24–50 µMG+: 18 µM G−: 36 µMG+: 12 µM G−: 12 µMG+: 16 µM G−: 32 µMG+: 25–60 µM G−: 10–30 µM
5 O. ishikawaeG+: 6–100 µM G−: not active F: 50 µM G+: 6–100 µM G−: 12–50 µM F: not active G+: 3–25 µM G−: 3–12 µM F: 50 µM G+: 3–25 µM G−: 12.5 µM F: 100 µM G+: 3–15 µM G−: 25–50 µM F: 50 µM Ishikawain: Unknown Palustrin-2: G+: 12–100 µM G−: 100 µM F: 100 µM Odorranain: Unknown
6 O. jingdongensisG+: 6–15 µM G−: 25–50 µM F: 50µM G+: 19 µM G−: 38 µM F: 19 µM G+: 8 µM G−: 34 µM F: not active G+: 8–16 µM G−: 15–16 µM F: 30–70 µM
7 O. livida Lividin 1–4: Unknown
8 O. schmakeriUnknown Unknown Unknown Unknown BRP: 7
9 O. tiannanensisUnknown Unknown Unknown Unknown Mararetaein, Pleurain, Odorranain: Unknown Tiannenensin: G+: 75 µM F:>100 µM
10 O. versablisUnknown Unknown Unknown Ranatuerins, Temporin, Trypsininhibitor: Unknown
Genus: PelophylaxBrevinin-1Brevinin-2Esculentin-1Esculentin-2 Novel family of Peptides
1 P. plancyi Unknown
2 P. porosus Unknown
3 P. chosenicus Unknown
4 P. fukienensisUnknown Unknown Unknown Pelophylaxin: Unknown Ranakinestatin: bradykinin antagonist
5 P. nigromaculata Unknown Nigocin-2 G+: 2.5 µg/mL G−: 10–100 µg/mL F: 150 µg/mL
Genus: RanaBrevinin-1Brevinin-2Temporin-1Ranatuerin-2 Novel family of Peptides
1R. amurensisUnknown 2
2R. brevipoda porsaG+: 8 µg/mL G−: 34 µg/mLG+: 8 µg/mL G−: 4 µg/mL
3R. chaochioensis JaponicinG+: 25–100 µg/mL G−: 12–100 µg/mL
4R. chensinensisG+: 12.5 µM G−: 25 µM HC50: 180–200 µM3G+: 100 µM G−: 100 µM IC50: 30–60 µM (Mcf 7 breast cancer cell line) LD50: 100 µM RCSK 1–4, Chensinin 1–4, Japonicin-1, D-1CDYa: G+: 6–8 µM G−: 3–5 µM HC50: 450 µM
5R. dybowskiiG+: 12.5 µM G−: 25 µM HC50: 125 µMG+: 15–30 µM G−: 15–30 µMG+: 60–100 µM G−: 60–100 µM HC50: 180 µM Japonicin-1:G+: 100 µM G−: 25 µM HC50: 300 µM
6R. japonica G+: >100 µM G−: >100 µM Japonicin-1:G+: >100 µM G−: 30 µM Japonicin-2:
G+: 20 µM G−: 12 µM
7R. okinavanaG+: 12.5 µM G−: 6–12.5 µM F: not active G+: 50 µM G−: 12.5 µM F: 100 µM
8R. ornativentris UnknownG+: 200 µM F: 200 µMUnknown Palustrin: Unknown
9R. piricaG+: 13µM G−: not active F: 100 µM HC50: 7 µMG+: 25 µM G−: 3–12 µM F: 100 µM HC50: 50 µMG+: 100 µM G−: not active F: 100 µM HC50: 300 µMG+: 100 µM G−: not active F: 100 µM HC50: 150 µM
10R. pleuradan Pleurain: G+: 15–30 µg/mL G−: 60–120 µg/mL F: 30 µg/mL
11R. sakurai G+: >50 µM G−: 3 µM F: not activeG+: 25 µM G−:>50 µM F: >50 µMG+: >50 µM G−: 50 µM F: >50 µM MRP (AR 23), BRP: Smooth muscle active peptides
12R. shuchinae Shuchin G+: 6–15 µg/mL G−: 3–50 µg/mL F: 6.25 µg/mL
13R. tagoiUnknown G+: 10–40 µM MRP (AR23): G+: 2–20 µM
14R. tagoiokiensisG+: 5 µM G−: 20 µM F: 20 µM G+: 10 µM G−: 160 µM F: 80µMG+: 160 µM G−: 80 µM F: 160 µM
15R. tsushimensisG+: 12–25 µM G−: 25–100 µM F: 50 µM LD50: 12 µMG+: 5 µM G−: 20 µM F: 20 µM LD50: 100 µMUnknown
Genus: Clinotarsus
1C. curtipesBrevinin-1 G+: 6–100 µg/mL G−: 7–60 µg/mL
Genus: Fejervaria
1F. carcrivoraTigerinin 2G+: 20–80 µg/mL G−: 10–40 µg/mL F: 80–180 µg/mL
Genus: Hoplobatracus
1H. rugulosusTigerinin 1: Insulin releasing peptide
2H. tigerinusTigerinin 1: G+: 20–50 µg/mL G−: 20–100 µg/mL
Genus : Hyla
1H. annectansAnnotoxin-1: Inhibitor of tetradotoxin sensitive sodium channel
Genus: Limnonectes
1L. fujianensisLimnonectin-2: G+: not active G−: 35–70 µM LD50: 160 µM
Genus: Nanorana
1N. parkeriJaponicin:G+: 9–40 µg/mL G−: >100 µg/mL Parkerin: G+: 37.5 µg/mL G−: 37–100 µg/mL
Genus: Rhacophorus
1R. duboisiPolypedarelaxin: Smooth muscle active peptide Polypedatein: Unknown
2R. SchegliiHistone 2B: Unknown
Genus: Sanguirana
1S. variansBLP: Smooth muscle active peptide
Genus: Euphlyctis
E. hexadactylusCrude skin extract: G+: 120–260 µg/mL G−: 120–520 µg/mL F: 32–64 µg/mL
G+: gram positive bacteria; G−: gram negative bacteria; F: fungi; LD50: mean lethal dose against RBC; IC50: drug concentration causing 50% inhibition against cancer cell lines.
Amolopins, a novel family of two peptides (P1 and P2), were isolated from A. loloesis and have shown potent antimicrobial activity [15]. Both peptides were effective against the tested gram-positive bacteria over a range of 37–75 µg/mL, though they were found not to be effective against the tested range of gram-negative bacteria. Amolopins also showed 3% hemolysis at 200 µg/mL [15]. Additionally, Amolopin 1 and Amolopin 6 were isolated from A. hainanensis [10], and Jindongenin—a novel family characterized from A. jindongensis—were found to be effective against gram positive (Minimal inhibitory concentration [MIC]: 17–60 µM), gram-negative bacteria (MIC: 10–40 µM) and fungi (Candida albicans: MIC 60 µM). Cytotoxicity analysis of Jindongenin from A. jindongensis against K562 and HT29 revealed that IC50 values ranged between 40–46 µM [11].
Hainanenins 1–5 were isolated from A. hainanensis [10] and also showed potent antimicrobial function against gram-positive bacteria, gram negative bacteria and fungi in the ranges 4–40 µg/mL, 4–75 µg/mL, and 2–75 µg/mL respectively. Three Bradykinin related peptides (BRPs) named Amolopkinins were found in A. loloesis and A. wuyiensis [16,17]. Amylopkinin from A. loloesis exhibited dose dependent contractile activity in guinea pig ileum [16]. The function of BRPs in frog skin secretion is thought to relate to smooth muscle contraction activity—if a predator swallows the frog, these peptides induce smooth muscle contractions that will result in a vomiting sensation, thereby allowing the frog to escape predation. Two other Amylopkinins from A. wuyiensis inhibited Bradykinin induced contractile effects on isolated rat ileum smooth muscle preparations [17].

2.2. Clinotarsus

The Clinotarsus genus is endemic to the Western Ghats of India where new HDPs are being discovered. The peptidomic approach revealed the presence of five novel peptide amides homologous to the Brevinin 1 family from a single species, C. curtipes, that all show promising effectiveness against gram-positive and gram-negative bacteria [81]. The MICs against the tested pathogenic bacteria were reported to be between 6–25 μg/mL (Table 1 and Table 2). It was previously reported that bacterial membranes depolarize during pore formation and bacterial killing, but in the case of Brevinin 1 from C. curtipes, it was shown that depolarization and bacterial killing are independent events. We are slowly beginning to understand the methods by which these HDPs effectively fight disease.

2.3. Euphlyctis

Ramesh B. et al. [92] reported on the potential of HDPs discovered on the skin of the Indian green frog, Euphlyctis hexadactylus. They showed that the lyophilized crude skin secretion was inhibiting the growth of pathogenic gram-positive and gram-negative bacteria, as well as fungal pathogens—which included plant fungal pathogens. The MIC of the peptide against several human-relevant bacteria ranged from 128 to 512 μg/mL and for fungus it ranged between 32 to 64 μg/mL (Table 1 and Table 2). However it has not yet been reported what the composition of these skin secretions might be.

2.4. Fejervarya

Two Tigerinin peptides were identified from Fejervarya cancrivora [82], similar to the Tigerinins originally isolated from the Indian frog Hoplobatrachus tigrinus. The effects of a C-terminal amidation on both peptides include a decrease in MIC against pathogens compared to their non-amidated counterparts. MICs of non-amidated Tigerinins against gram-positive bacteria, gram-negative bacteria and fungi ranged from 20–80 µg/mL, 10–40 µg/mL and 80–180 µg/mL respectively (Table 1 and Table 2) and that of C terminally amidated peptides were 10–40 µg/mL, 5–40 µg/mL, and 15 µg/mL respectively. They also exhibited 10%–12% hemolysis against rabbit red blood cells (RBCs) at 100 µg/mL [82]. With this data we can better understand the influence of the peptide’s sequence on its function.

2.5. Glandirana

HDPs with significant antimicrobial activity have been reported from two species of genus Glandirana—G. rugosus [13,18] and G. emeljanovi [19] (Table 1). Novel peptides such as Rugocin A–C and Gaegurins 1–3 (6 peptides) were characterized from G. rugosus, which is now reclassified as the Brevinin 2 family [20]. Gaegurins 5–6 from G. emeljanovi have been reclassified as the Brevinin 1 family [20], and Gaegurin 4 as Esculentin 2 [19]. MICs of Brevinin-2 (Rugosin A and B) from G. rugosus were found to be 6–50 µg/mL for gram-positive bacteria and 12.5–100 µg/mL for gram-negative bacteria (Table 1 and Table 2) [18].

2.6. Hoplobatrachus

Tigerinins, first reported in H. tigerinus, [83] are a family of 4 peptides identified in H. rugulosus that are characterized by potent antimicrobial activity against gram-positive bacteria (MICs: 20–50 µg/mL) and gram-negative bacteria (MICs: 20–100 µg/mL) (Table 1 and Table 2). Tigerinins isolated from H. rugulosus have also been found to stimulate insulin release from rat BRIN-BD11 clonal β cell line [84,85]. Ojo et al. [84] also reported that C-terminal amidation was crucial for its activity.

2.7. Hyla

Anntoxin, a peptide that inhibits tetradotoxin-sensitive voltage-gated sodium channels, was identified in the skin secretions of Hyla annectans. This peptide is believed to have a great therapeutic potential as an anti-nociceptive and anti-inflammatory agent [86] (Table 1 and Table 2).

2.8. Hylarana

Many of the peptides isolated from the different Hylarana species belong to the Brevinin 1 and 2, Esculentin 2, and Temporin families, and have showed activity against gram-positive and -negative bacteria, fungi and cancer cells (Table 1 and Table 2) [21,22,23,24,25,26,27,28,29,30]. Gaegurins (7 peptides) and Rugosins (9 peptides) from H. nigrovittata have been reclassified to the families Brevinin 1 and 2, respectively [27]. Brevinin 2 from H. guentherii was also able to stimulate insulin secretion from the rat BRIN-BDII clonal β cell line [25].
H. nigrovittata and H. spinulosa also produce a novel family of antimicrobial peptides [27,30] called the Nigroain family, which exhibited activity against gram-positive bacteria (MICs: 9–50 µg/mL), gram-negative bacteria (MICs: 25–110 µg/mL) and fungi (MICs: 2–4 µg/mL). Bradykinin-like peptides identified from this genus include Ranakinin N and Cholycytokinin from H. nigrovittata, as well as BRPs from H. guentherii [31,32,33]. Ranakinin N induced dose-dependent contractile effects on guinea pig ileum [32] and BRPs from H. guentherii revealed dose-dependent contraction of intestinal smooth muscle but did not have any effect on rat arterial smooth muscle [33].
Antimicrobial peptide Guentherin was first reported from H. guentherii and showed potent activity only against gram-positive bacteria (MIC: 33.5 µg/mL) [33]. Odorranain, another novel peptide of Odorrana genus, was identified from H. spinulosa [30]. Antimicrobial peptide Esculentin 1 was identified in three Hylarana species: H. latouchii, H. spinulosa and H. luctuosa [8,24,30]. Palustrin 2 was reported from H. latouchii, H. signata and H. luctuosa [24,29]. Palustrin 2, found on H. latouchii, was active only against gram-positive bacteria (MICs: 1–14 µM). Three peptide familes, Ranateurin, Ranacyclin, and Spinulosain were uniquely found in H. spinulosa [30]. These three peptides did not show any antimicrobial activity against the tested pathogens but Ranatuerin exhibited very low hemolysis of 10% at 200 µM against rabbit RBCs.
H.temporalis is the first among the genus to be reported from Western Ghats, India. Seven novel peptides are reported from H.temporalis, which include one Brevinin 1, two Brevinin 2 peptides, three Esculentin 2 peptides, and one Hylaranakinin peptide [34,35,36]. The MICs of Brevinin and Esculentin peptides ranges from 30 to 150 μg/mL.

2.9. Limnonectus

Limnonectins (2 peptides) from L. fujianensis are the only family of HDPs reported from the genus Limnonectus thus far [87] (Table 1 and Table 2). These peptides were reported to have no antimicrobial activity towards gram-positive bacteria and fungi, but MICs against gram-negative bacteria range between 35–70 µM. They exhibited no hemolysis up to a concentration of 160 µM.

2.10. Nanorana

Genus Nanorana has provided the antimicrobial peptides Japonicin 1 (2 peptides) and a novel family named Parkerin, both isolated from N. parkeri [88] (Table 1 and Table 2). Japonicin 1 and Parkerin peptides were reported to be effective only against gram-positive bacteria with MICs in the range 9–37 µg/mL and 37–40 µg/mL respectively. 1%–3% hemolysis was observed for both peptides at 80 µg/mL. Mast cell degranulation, which is thought to mediate antimicrobial activity of HDPs, was exhibited by both the peptides.

2.11. Odorrana

HDPs have been identified from ten species of Odorrana (Table 1). O. grahamii is one of the well-studied species in Asia. Common peptide families include Brevinin 1 and 2, Esculentin 1 and 2, and Nigrocin 2 [28,31,37,38,39,40,41,42,43,44,45,46,47], all of which have been shown to be effective against gram-positive and -negative bacteria, as well as fungi. A novel antimicrobial peptide family, Odorranain, was reported from four species of the genus [14,37,41,42,48,49]. MICs of Odorranain peptides against gram-positive bacteria, gram-negative bacteria and fungi were in the ranges 2–90 µg/mL, 3–50 µg/mL and 1–50 µg/mL, respectively. MIC of Odorranain towards Helicobacter pylori was reported to be 20 µg/mL (Table 1 and Table 2).
Many novel peptide families were reported from O. grahamii such as Tachykinin (2 peptides), Odorranalectin (the smallest lectin reported so far), 5 Bombesin-like peptide, and 2 Grahamins [37,48,49,50,51,52]. Odorranalectin coupled with a nanoparticle complex improved the therapeutic effects of UCN-loaded nanoparticle in treating Parkinson’s disease. Results also suggested the use of Odorranalactin as a carrier in nasal delivery of macromolecular drugs to the brain [53]. Antimicrobial activity of Grahamins was reported against gram-positive bacteria (MIC: 2.5 µg/mL), gram-negative bacteria (MICs: 1–8 µg/mL) and fungi (MIC: 7.5 µg/mL). Trypsin inhibitor peptide was isolated from O.grahamii, O. versablis, and O. hejiangensis. These inhibitors are thought to protect the host from a range of proteases produced by invading pathogens [47,54,55].
Studies of the skin of O. tiannanensis also revealed a set of novel HDP families—Margaretaein (2 peptides), Pleurain, and Tiannanensin [42]. Tiannanensin, an antimicrobial peptide, showed activity against gram-positive bacteria and fungi with MICs 75 and >100 µM, respectively. In addition to these there are other novel HDP families including Iksikawain, Lividin (first report), and Ranateurin, found in O. ishikawae, O. livida, and O. versablis, respectively [41,43,56]. Bradykinin related peptides were also isolated from O. grahamii (3 peptides) and O. schmakeri (7 peptides) [57,58]. Three of the five Bombesin-like peptides from O. grahamii induced contraction of the stomach muscle tissue. The other two BLPs, which have a C terminal octapeptide, antagonized stomach muscle contraction. Inhibition of contraction is thought to be due to the presence of the octapeptide [37].

2.12. Pelophylax

Five species of the genus Pelophylax (P. plancyi, P. porosus, P. chosensicus, P. nigromaculata, and P. fukienensis) are well-known for their HDPs (Table 1 and Table 2). Pelophylaxins 1–4 are a novel peptide group with no orthologs, and are found in P. fukienensis [56]. Two other novel peptides, Nigrocin 1 and 2, were isolated from P. nigromaculata [13,59] and later reclassified to the Brevinin 2 family [20]. Brevinin 2 (Nigrocin 1) was reported to have antimicrobial activity towards gram-positive bacteria (MIC: 2.5 µg/mL), gram-negative bacteria (MIC: 10–100 µg/mL), and fungi (MIC: 100 µg/mL). Nigrocin 2 was also reported to be effective against gram-positive and gram-negative bacteria as well as fungi in the ranges 2.5 µg/mL, 10–200 µg/mL, and 150 µg/mL, respectively. Both of the peptides from P. nigroemaculata showed low hemolysis of 0.9%–1% at 100 µg/mL. A Bradykinin antagonist named Ranakenestatin was recently reported from P. fukienensis—though the exact function of this peptide in frogs remains controversial, it is expected to have great potential in therapeutic applications [60].

2.13. Rana

Rana is one of the most diverse and well-studied of the amphibian genera in Asia with respect to their host defense peptides. HDPs have been isolated from 16 different species (Table 1 and Table 2). Common antimicrobial peptide families that were identified from this genus include Brevinin 1 and 2, Ranateurin, and Temporin 1 [61,62,63,64,65,66,67,68,69,70,71,72,73,74,75]. Temporin 1 from R. chensinensis exhibited cytotoxic effects against 12 tested carcinoma cell lines. They also showed low hemolytic effect against human RBCs and no considerable cytotoxic activity against normal human umbilical vein smooth muscle cells (HUVSMCs).
Japonicin 1 and 2, first isolated from R. japonica, were isolated from three other species of the genus [62,64,65,74]. Japonicins were found to be effective against gram-positive and gram-negative bacteria in the range of 25–100 µg/mL and 12–100 µg/mL respectively. They were also reported to be strongly hemolytic against mammalian RBCs.
Amurins reported from R. amurensis and Dybowskins from R. Dybowsskii (1–6: 6 peptides) [62] have been reclassified to the Brevinin 1 family [20]. Palustrin 1, first identified from R. palustris, was also reported from R. ornativentris [67]. Mellitin related peptides (MRPs) were isolated from R. tagoi and R. sakuraii [70,76]. MRPs are active against gram-positive bacteria, gram-negative bacteria, and fungi. Bradykinin related peptides were reported from R. okienensis, R. tagoi, R. chensinensis and R. sakuraii [69,71,72,77]. Shuchin (5 peptides) and Pleuran, two novel peptide families, were identified from R. shuchinae and R. pleuridan, respectively, both of which are potent against gram-positive and -negative bacteria, as well as fungi [78,79,80].

2.14. Rhacophorus

HDPs from two species—Rhacophorus duboisi (previously Polypedates pingbianensis) and Rhacophorus schegelii—have recently been isolated (Table 1 and Table 2). Polypedarelaxin from Rhacophorus duboisi effectively relaxes smooth muscle contractions [89]. This peptide exhibited concentration-dependent relaxation effects on isolated rat ileum but did not show antimicrobial and serine protease activity. Cationic antimicrobial peptides do not appear in the dermal immune system of Rhacophorus schegelii [90]. However, Histone 2B was reported from Rhacophorus schegelii, [90] which is evidence for the role of histones as antimicrobials in addition to their ability to remodel chromatin. This was the first report of histones from frog skin secretion.

2.15. Sanguirana

HDPs isolated from Sanguirana varians (Table 1 and Table 2) of the genus Sanguirana revealed homology to the neuroendocrine peptide Bombesin [91]. These BLPs revealed dose dependent contractile effects of stomach tissue.

3. Conclusions

With the increasing emergence of multi-drug resistant pathogens, as well as the constant struggle against non-infectious illnesses such as cancer, there is a critical need to develop new therapies where old treatments have failed. Amphibian-derived antimicrobial peptides offer us a potential solution. We are now just beginning to understand the diversity and functions of these peptides, but this review outlines the ways in which we already see the potential clinical uses of these HBPs. The potent antimicrobial peptides in Asian frogs belong to the Brevinin and Esculentin. They are very effective against gram-positive and negative-bacteria as well as fungi. The only problem with these peptides is their high cytotoxicity, which would be eliminated by effective modification. The Temporin family of peptides are potent anticancer agents which are highly toxic against cancer cells, especially breast cancer cell lines and demonstrate very low toxicity towards normal cells (e.g., temporin from R. chensinensis). Hopefully further study of these animals and their skin peptides will reveal novel therapies that may potentially fill the gap left by antibiotic resistance and the failure of many of our current cancer treatments. There is therefore a need to turn our attention to this region and its biodiversity as a key medical resource.

Acknowledgments

Vineeth T.V. Kumar and Sanil George are thankful to Kerala State Council for Science, Technology and Environment (KSCSTE), Govt. of Kerala, India for financial assistance. Grant No: (No.006/SRSLS/2011/CSTE).

Author Contributions

Vineeth T.V. Kumar, David Holthausen, Joshy Jacob and Sanil George wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix

Antibiotics 04 00136 g001 1024
Figure A1. Multiple sequence alignment of Brevinin-1 from Asian frogs.
Figure A1. Multiple sequence alignment of Brevinin-1 from Asian frogs.
Antibiotics 04 00136 g001
Antibiotics 04 00136 g002 1024
Figure A2. Multiple sequence alignment of Brevinin-2 from Asian frogs.
Figure A2. Multiple sequence alignment of Brevinin-2 from Asian frogs.
Antibiotics 04 00136 g002
Antibiotics 04 00136 g003 1024
Figure A3. Multiple sequence alignment of Esculetin-1 from Asian frogs.
Figure A3. Multiple sequence alignment of Esculetin-1 from Asian frogs.
Antibiotics 04 00136 g003
Antibiotics 04 00136 g004 1024
Figure A4. Multiple sequence alignment of Esculetin-2 from Asian frogs.
Figure A4. Multiple sequence alignment of Esculetin-2 from Asian frogs.
Antibiotics 04 00136 g004

References

  1. Aoki, W.; Kuroda, K.; Ueda, M. Next generation of antimicrobial peptides as molecular targeted medicines. J. Biosci. Bioeng. 2012, 114, 365–370. [Google Scholar] [CrossRef] [PubMed]
  2. Erspamer, V. Bioactive secretions of the integument. In Amphibian Biology. The Integument; Heatwole, H., Barthalamus, G., Eds.; Surrey Beatty & Sons: Chipping Norton, Australia, 1994; Volume 1, pp. 179–350. [Google Scholar]
  3. Nicolas, P.; Vanhoye, D.; Amiche, M. Molecular strategies in biological evolution of antimicrobial peptides. Peptides 2003, 24, 1669–1680. [Google Scholar] [CrossRef] [PubMed]
  4. Galdiero, S.; Falanga, A.; Cantisani, M.; Vitiello, M.; Morelli, G.; Galdiero, M. Peptide-lipid interactions: Experiments and applications. Int. J. Mol. Sci. 2013, 14, 18758–18789. [Google Scholar] [CrossRef] [PubMed]
  5. Calderon, L.A.; Stabeli, R.G. Anuran amphibians: A huge and threatened factory of a variety of active peptides with potential nanobiotechnological applications in the face of amphibian decline. Available online: http://cdn.intechopen.com/pdfs-wm/23583.pdf (accessed on 2 December 2014).
  6. Calderon, L.A.; Soares, A.M.; Stábeli, R.G. Anuran antimicrobial peptides: An alternative for the development of nanotechnological based therapies for multidrug—Resistant infections. Available online: http://signpostejournals.com/ejournals/Portals/5/25-161-1-PB.pdf (accessed on 2 December 2014).
  7. Conlon, J.M.; Sonnevend, A. Clinical applications of amphibian antimicrobial peptides. J. Med. Sci. 2011, 4, 62–72. [Google Scholar]
  8. Conlon, J.M.; Mechkarska, M.; Lukic, M.L.; Flatt, P.R. Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides 2014, 57, 67–77. [Google Scholar] [CrossRef] [PubMed]
  9. Lu, Y.; Li, J.; Yu, H.; Xu, X.; Liang, J.; Tian, Y.; Mab, D.; Lin, G.; Huang, G.; Lai, R. Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis. Peptides 2006, 27, 3085–3091. [Google Scholar] [CrossRef] [PubMed]
  10. Zhang, S.; Guo, H.; Shi, F.; Wang, H.; Li, L.; Jiao, X.; Wang, Y.; Yu, H. Hainanenins: A novel family of antimicrobial peptides with strong activity from Hainan cascade-frog, Amolops hainanensis. Peptides 2012, 33, 251–257. [Google Scholar] [CrossRef] [PubMed]
  11. Chen, Z.; Yang, X.; Liu, Z.; Zeng, L.; Lee, W.; Zhang, Y. Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis. Biochimie 2012, 94, 328–334. [Google Scholar] [CrossRef] [PubMed]
  12. Wang, M.; Wang, Y.; Wang, A.; Song, Y.; Ma, D.; Yang, H.; Ma, Y.; Lai, R. Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis. Comp. Biochem. Physiol. 2010, 155, 72–76. [Google Scholar] [CrossRef]
  13. Yang, X.; Xia, J.; Yu, Z.; Hu, Y.; Li, F.; Meng, H.; Yang, S.; Liu, J.; Wang, H. Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis. Peptides 2012, 38, 41–53. [Google Scholar] [CrossRef] [PubMed]
  14. Wang, H.; Ran, R.; Yu, H.; Yu, Z.; Hu, Y.; Zheng, H.; Wang, D.; Yang, F.; Liu, R.; Liu, J. Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae). Peptides 2012, 33, 27–34. [Google Scholar] [CrossRef] [PubMed]
  15. Wang, A.; Wang, J.; Hong, J.; Feng, H.; Yang, H.; Yu, X.; Ma, Y.; Lai, R. A novel family of antimicrobial peptides from the skin of Amolops loloensis. Biochimie 2008, 90, 863–867. [Google Scholar] [CrossRef] [PubMed]
  16. Liang, J.; Han, Y.; Li, J.; Xu, X.; Rees, H.; Lai, R. A novel bradykinin-like peptide from skin secretions of rufous-spotted torrent frog, Amolops loloensis. Peptides 2006, 27, 2683–2687. [Google Scholar] [CrossRef] [PubMed]
  17. Zhou, X.; Wang, L.; Zhou, M.; Chen, T.; Ding, A.; Rao, P.; Walker, B.; Shaw, C. Amolopkinins W1 and W2—Novel bradykinin-related peptides (BRPs) from the skin of the Chinese torrent frog, Amolops wuyiensis: Antagonists of bradykinin-induced smooth muscle contraction of the rat ileum. Peptides 2009, 30, 893–900. [Google Scholar] [CrossRef] [PubMed]
  18. Suzuki, S.; Okobo, T.; Kakegawa, T.; Tatemoto, K. Isolation and characterization of antimicrobial peptides, rugosins A, B, and C, from the skin of the frog, Rana rugosa. Biochem. Biophys. Res. Commun. 1995, 212, 249–254. [Google Scholar] [CrossRef] [PubMed]
  19. Won, H.; Kang, S.; Lee, B. Action mechanism and structural requirements of the antimicrobial peptides, gaegurins. Biochim. Biophys. Acta 2009, 1788, 1620–1629. [Google Scholar] [CrossRef] [PubMed]
  20. Conlon, J.M. Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae. Peptides 2008, 29, 1815–1819. [Google Scholar] [CrossRef]
  21. Al-Ghaferi, N.; Kolodziejek, J.; Nowotny, N.; Coquet, L.; Jouenne, T.; Leprince, J.; Vaudry, H.; King, J.D.; Conlon, J.M. Antimicrobial peptides from the skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae). Peptides 2009, 31, 548–554. [Google Scholar] [CrossRef] [PubMed]
  22. Wang, H.; Lu, Y.; Zhang, X.; Hu, Y.; Yu, H.; Liu, J.; Sun, J. The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura: Ranidae). Peptides 2009, 30, 273–282. [Google Scholar] [CrossRef] [PubMed]
  23. Wang, H.; Yan, X.; Yu, H.; Hu, Y.; Yu, Z.; Zheng, H.; Chen, Z.; Zhang, Z.; Liu, J. Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae). Biochimie 2009, 91, 540–547. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, H.; Yu, Z.; Hu, Y.; Yu, H.; Ran, R.; Xia, J.; Wang, D.; Yang, S.; Yang, X.; Liu, J. Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Biochimie 2012, 94, 1317–1326. [Google Scholar] [CrossRef] [PubMed]
  25. Conlon, J.M.; Power, G.J.; Abdel-Wahab, Y.H.A.; Flatt, P.R.; Jiansheng, H.; Coquet, L.; Leprince, J.; Jouenne, T.; Vaudry, H. A potent, non-toxic insulin-releasing peptide isolated from an extract of the skin of the Asian frog, Hylarana guntheri (Anura: Ranidae). Regul. Pept. 2008, 29, 151–153. [Google Scholar]
  26. Zhou, J.; McClean, S.; Thompson, A.; Zhang, Y.; Shaw, C.; Rao, P.; Bjourson, A.J. Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri. Peptides 2006, 27, 3077–3084. [Google Scholar] [CrossRef] [PubMed]
  27. Ma, Y.; Liu, C.; Liu, X.; Wu, J.; Yang, H.; Wang, Y.; Li, J.; Yu, H.; Lai, R. Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Genomics 2010, 95, 66–71. [Google Scholar] [CrossRef] [PubMed]
  28. Conlon, J.M.; Kolodziejek, J.; Nowotny, N.; Leprince, J.; Vaudry, H.; Coquet, L.; Jouenne, T.; King, J.D. Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae). Toxicon 2008, 52, 465–473. [Google Scholar] [CrossRef] [PubMed]
  29. Conlon, J.M.; Kolodziejek, J.; Mechkarska, M.; Coquet, L.; Leprince, J.; Jouenne, T.; Vaudry, H.; Nielsen, P.F.; Nowotny, N.; King, J.D. Host defense peptides from Lithobates forreri, Hylarana luctuosa, and Hylarana signata (Ranidae): Phylogenetic relationships inferred from primary structures of ranatuerin-2 and brevinin-2 peptides. Comp. Biochem. Physiol. 2014, D9, 49–57. [Google Scholar]
  30. Yang, X.; Hu, Y.; Xu, S.; Hu, Y.; Meng, H.; Guo, C.; Liu, Y.; Liu, J.; Yu, Z.; Wang, H. Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae). Biochimie 2013, 95, 2429–2436. [Google Scholar] [CrossRef] [PubMed]
  31. Liu, X.; Wang, Y.; Cheng, L.; Song, Y.; Lai, R. Isolation and cDNA cloning of cholecystokinin from the skin of Rana nigrovittata. Peptides 2007, 28, 1540–1544. [Google Scholar] [CrossRef] [PubMed]
  32. Liu, X.; You, D.; Chen, L.; Wang, X.; Zhang, K.; Lai, R. A novel bradykinin-like peptide from skin secretions of the frog, Rana nigrovittata. J. Pept. Sci. 2008, 14, 626–630. [Google Scholar] [CrossRef] [PubMed]
  33. Zhou, J.; B jourson, A.J.; Coulter, D.J.M.; Chen, T.; Shaw, C.; Rourke, M.O.; Hirst, D.G.; Zhang, Y.; Rao, P.; McClean, S. Bradykinin- related peptides, including a novel structural variant, (Val1)-bradykinin, from the skin secretion of Guenther’s frog, Hylarana guentheri and their molecular precursors. Peptides 2007, 28, 781–789. [Google Scholar] [CrossRef] [PubMed]
  34. Reshmy, V.; Preeji, V.; Parvin, A.; Santhoshkumar, K.; George, S. Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae). J. Pept. Sci. 2011, 17, 342–347. [Google Scholar] [CrossRef]
  35. Reshmy, V.; Santhosh Kumar, K.; George, S. Full length cDNA derived novel peptides belonging to Esculentin Family from skin of Indian Bronzed Frog Hylarana temporalis. Res. J. Biotech. 2011, 6, 71–74. [Google Scholar]
  36. Reshmy, V.; Preeji, V.; Parvin, A.; Santhosh Kumar, K.; George, S. Molecular cloning of a novel Bradykinin- related peptide from the skin of Indian bronzed frog Hylarana temporalis. J. Genomics Insights. 2010, 3, 23–28. [Google Scholar]
  37. Li, J.; Yu, H.; Xu, X.; Wang, X.; Liu, D.; Lai, R. Multiple bombesin-like peptides with opposite functions from skin of Odorrana grahami. Genomics 2007, 89, 413–418. [Google Scholar] [CrossRef] [PubMed]
  38. Conlon, J.M.; Leprince, J.; Vaudry, H.; Jiansheng, H.; Nielsen, P.F. A family of antimicrobial peptides related to japonicin-2 isolated from the skin of the chaochiao brown frog Rana chaochiaoensis. Comp. Biochem. Physiol. 2006, 144, 101–105. [Google Scholar] [CrossRef]
  39. Wang, H.; Yu, Z.; Hu, Y.; Li, F.; Liu, L.; Zhen, H.; Meng, H.; Yang, S.; Yang, X.; Liu, J. Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis. Peptides 2012, 35, 285–290. [Google Scholar]
  40. Iwakoshi-Ukena, E.; Ukena, K.; Okimoto, A.; Soga, M.; Okada, G.; Sano, N.; Fujii, T.; Sugawara, Y.; Sumida, M. Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae. Peptides 2011, 32, 670–676. [Google Scholar] [CrossRef] [PubMed]
  41. Iwakoshi-Ukena, E.; Soga, M.; Okada, G.; Fujii, T.; Sumida, M.; Ukena, K. Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning. Biochem. Biophys. Res. Commun. 2011, 412, 673–677. [Google Scholar] [CrossRef] [PubMed]
  42. He, W.; Feng, F.; Huang, Y.; Guo, H.; Zhang, S.; Zheng, Li.; Liu, J.; Wang, Y.; Yu, H. Host defense peptides in skin secretions of Odorrana tiannanensis: Proof for other survival strategy of the frog than merely anti-microbial. Biochimie 2012, 94, 649–655. [Google Scholar] [CrossRef] [PubMed]
  43. Chen, T.; Li, L.; Zhou, M.; Rao, P.; Walker, B.; Shaw, C. Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: Identification of novel brevinins from three species of Chinese frogs. Peptides 2006, 27, 42–48. [Google Scholar] [CrossRef] [PubMed]
  44. Chen, T.; Zhou, M.; Chen, W.; Lorimer, J.; Rao, P.; Walker, B.; Shaw, C. Cloning from tissue surrogates: Antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs. Genomics 2006, 87, 638–644. [Google Scholar] [CrossRef] [PubMed]
  45. Chen, T.; Zhou, M.; Rao, P.; Walker, B.; Shaw, C. The Chinese bamboo leaf odorous frog (Rana (Odorrana) versabilis) and North American Rana frogs share the same families of skin antimicrobial peptides. Peptides 2006, 27, 1738–1744. [Google Scholar] [CrossRef] [PubMed]
  46. Quan, Z.; Zhou, M.; Chen, W.; Chen, T.; Walker, B.; Shaw, C. Novel brevinins from Chinese piebald odorous frog (Huia schmackeri) skin deduced from cloned biosynthetic precursors. Peptides 2008, 29, 1456–1460. [Google Scholar] [CrossRef] [PubMed]
  47. Zhou, M.; Chen, T.; Walker, B.; Shaw, C. Lividins: Novel antimicrobial peptide homologs from the skin secretion of the Chinese Large Odorous frog, Rana (Odorrana) livida—Identification by “shotgun” cDNA cloning and sequence analysis. Peptides 2008, 27, 2118–2123. [Google Scholar] [CrossRef]
  48. Che, Q.; Zhou, Y.; Yang, H.; Li, J.; Xu, X.; Lai, R. A novel antimicrobial peptide from amphibian skin secretions of Odorrana grahami. Peptides 2008, 29, 529–535. [Google Scholar] [CrossRef] [PubMed]
  49. Chen, L.; Li, Y.; Li, J.; Xu, X.; Lai, R.; Zou, Q. An antimicrobial peptide with antimicrobial activity against Helicobacter pylori. Peptides 2007, 28, 1527–1531. [Google Scholar] [CrossRef] [PubMed]
  50. Li, J.; Liu, T.; Xu, X.; Wang, X.; Wu, M.; Yang, H.; Lai, R. Amphibian tachykinin precursor. Biochem. Biophys. Res. Commun. 2006, 350, 983–986. [Google Scholar] [CrossRef] [PubMed]
  51. Li, J.; Wu, H.; Hong, J.; Xu, X.; Yang, H.; Wu, B.X.; Wang, Y.P.; Zhu, J.; Lai, R.; Jiang, X.; et al. Odorranalectin is a small peptide lectin with potential for drug delivery and targeting. PLOS ONE 2008, 3. [Google Scholar] [CrossRef] [PubMed]
  52. Li, J.; Xu, X.; Xu, C.; Zhou, W.; Zhang, K.; Yu, H.; Zhang, Y.; Zheng, Y.; Rees, H.H.; Lai, R.; et al. Anti-infection peptidomics of amphibian skin. Mol. Cell. Proteomics 2007, 6, 882–894. [Google Scholar] [CrossRef] [PubMed]
  53. Wen, Z.; Yan, Z.; Hu, K.; Pang, Z.; Cheng, X.; Guo, L.R.; Zhang, Q.; Jiang, X.; Fang, L.; Lai, R. Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson’s disease following intranasal administration. J. Control. Release 2011, 151, 131–138. [Google Scholar] [CrossRef] [PubMed]
  54. Li, J.; Wu, J.; Wang, Y.; Xu, X.; Liu, T.; Lai, R.; Zhu, H. A small trypsin inhibitor from the frog of Odorrana grahami. Biochimie 2008, 90, 1356–1361. [Google Scholar] [CrossRef] [PubMed]
  55. Wang, M.; Wang, L.; Chen, T.; Walker, B.; Zhou, M.; Sui, D.; Conlon, J. M.; Shaw, C. Identification and molecular cloning of a novel amphibian Bowman Birk-type trypsin inhibitor from the skin of the Hejiang Odorous Frog; Odorrana hejiangensis. Peptides 2012, 33, 245–250. [Google Scholar] [CrossRef] [PubMed]
  56. Zhou, M.; Chen, T.; Walker, B.; Shaw, C. Pelophylaxins: Novel antimicrobial peptide homologs from the skin secretion of the Fukien gold-striped pond frog, Pelophylax plancyi fukienensis Identification by “shotgun” cDNA cloning and sequence analysis. Peptides 2006, 27, 36–41. [Google Scholar] [CrossRef] [PubMed]
  57. Chen, M.; Che, Q.; Wang, X.; Li, J.; Yang, H.; Li, D.; Zhang, K.; Lai, R. Cloning and characterization of the first amphibian bradykinin gene. Biochimie 2010, 92, 226–231. [Google Scholar] [CrossRef] [PubMed]
  58. Li, L.; Bjourson, A. J.; He, J.; Cai, G.; Rao, P.; Shaw, C. Bradykinins and their cDNA from piebald odorous frog, Odorrana schmackeri, skin. Peptides 2003, 24, 863–872. [Google Scholar] [CrossRef] [PubMed]
  59. Park, S.; Park, S.; Ahn, H.; Kim, S.; Kim, S.S.; Lee, B.J.; Lee, B. Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata. FEBS Lett. 2001, 507, 95–100. [Google Scholar] [CrossRef] [PubMed]
  60. Ma, J.; Luo, Y.; Ge, L.; Wang, L.; Zhou, M.; Zhang, Y.; Duan, J.; Chen, T.; Shaw, C. Ranakinestatin-PPF from the skin secretion of the Fukien Gold-Striped Pond Frog, Pelophylax plancyi fukienensis: A Prototype of a novel class of Bradykinin B2 receptor antagonist peptide from ranid frogs. Sci. World J. 2014. [Google Scholar] [CrossRef]
  61. Conlon, J.M.; Al-Ghaferi, N.; Abraham, B.; Sonnevend, A.; Coquet, L.; Leprince, J.; Jouenne, T.; Vaudry, H.; Iwamuro, S. Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis. Comp. Biochem. Physiol. 2006, 143, 42–49. [Google Scholar] [CrossRef]
  62. Jin, L.L.; Li, Q.; Song, S.; Feng, K.; Zhang, D.; Wang, Q.; Chen, Y. Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii. Comp. Biochem. Physiol. 2009, 154, 174–178. [Google Scholar] [CrossRef]
  63. Conlon, J.M.; Kolodziejek, J.; Nowotny, N.; Leprincec, J.; Vaudry, H.; Coquet, L.; Jouenne, T.; Iwamuro, S. Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii. Toxicon 2007, 50, 746–756. [Google Scholar] [CrossRef] [PubMed]
  64. Jin, L.L.; Song, S.S.; Li, Q.; Chen, Y.H.; Wang, Q.Y.; Hou, S.T. Identification and characterisation of a novel antimicrobial polypeptide from the skin secretion of a Chinese frog (Rana chensinensis). Int. J. Antimicrob. Agents 2009, 33, 538–542. [Google Scholar] [CrossRef] [PubMed]
  65. Isaacson, T.; Soto, A.; Iwamuro, S.; Knoop, F.C.; Conlon, J.M. Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica. Peptides 2002, 23, 419–425. [Google Scholar] [CrossRef] [PubMed]
  66. Conlon, J.M.; Sonnevend, A.; Jouenne, T.; Coquet, L.; Cosquer, D.; Vaudry, H.; Iwamuro, S. A family of acyclic brevinin-1 peptides from the skin of the Ryukyu brown frog Rana okinavana. Peptides 2005, 26, 185–190. [Google Scholar] [CrossRef] [PubMed]
  67. Ohnuma, A.; Conlon, J.M.; Yamaguchi, K.; Kawasaki, H.; Coquet, L.; Leprince, J.; Jouenne, T.; Vaudry, H.; Iwamuro, S. Antimicrobial peptides from the skin of the Japanese mountain brown frog Rana ornativentris: Evidence for polymorphism among preprotemporin mRNAs. Peptides 2007, 24, 524–532. [Google Scholar] [CrossRef]
  68. Conlon, J.M.; Sonnevend, A.; Patel, M.; Al-Dhaheri, K.; Nielsen, P.F.; Kolodziejek, J.; Nowotny, N.; Iwamuro, S.; Pal, T. A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Regul. Pept. 2004, 118, 135–141. [Google Scholar] [CrossRef] [PubMed]
  69. Suzuki, H.; Iwamuro, S.; Ohnuma, A.; Coquet, L.; Leprince, J.; Jouenne, T.; Vaudry, H.; Taylor, C.K.; Abel, P.W.; Conlon, J.M. Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii. Peptides 2007, 28, 505–514. [Google Scholar] [CrossRef] [PubMed]
  70. Conlon, J.M.; Sonnevend, A.; Patel, M.; Camasamudram, V.; Nowotny, N.; Zilahi, E.; Iwamuro, S.; Nielsen, P.F.; Pal, T. A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties. Biochem. Biophys. Res. Commun. 2003, 306, 496–500. [Google Scholar] [CrossRef] [PubMed]
  71. Iwamuro, S.; Nakamura, M.; Ohnuma, A.; Conlon, J.M. Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi. Peptides 2006, 27, 2124–2128. [Google Scholar] [CrossRef] [PubMed]
  72. Tazato, S.; Conlon, M.J.; Iwamuro, S. Cloning and expression of genes enocoding antimicrobial peptides and bradykinin from the skin and brain of Oki Tago’s brown frog, Rana tagoi okiensis. Peptides 2010, 31, 1480–1487. [Google Scholar] [CrossRef] [PubMed]
  73. Conlon, J.M.; Coquet, L.; Jouenne, T.; Leprince, J.; Vaudry, H.; Iwamuro, S. Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies. Toxicon 2010, 55, 430–435. [Google Scholar] [CrossRef] [PubMed]
  74. Conlon, J.M.; Al-Ghaferi, N.; Abraham, B.; Jiansheng, H.; Cosette, P.; Leprince, J.; Jouenne, T.; Vaudry, H. Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Peptides 2006, 27, 2111–2117. [Google Scholar] [CrossRef] [PubMed]
  75. Morikawa, N.; Hagiwari, K.; Nakajima, T. Brevinin 1 and 2, unique antimicrobial peptides from skin of the frog Rana brevipoda porsa. Biochem. Biophys. Res. Commun. 1992, 189, 184–190. [Google Scholar] [CrossRef] [PubMed]
  76. Suzuki, H.; Conlon, J.M.; Iwamuro, S. Evidence that the genes encoding the melittin-related peptides in the skins of the Japanese frogs Rana sakuraii and Rana tagoi are not orthologous to bee venom melittin genes: Developmental- and tissue-dependent gene expression. Peptides 2007, 28, 2061–2068. [Google Scholar] [CrossRef] [PubMed]
  77. Sin, Y.; Zhou, M.; Chen, W.; Wang, L.; Chen, T.; Walker, B.; Shaw, C. Skin bradykinin-related peptides (BRPs) and their biosynthetic precursors (kininogens): Comparisons between various taxa of Chinese and North American ranid frogs. Peptides 2008, 29, 393–403. [Google Scholar] [CrossRef] [PubMed]
  78. Zheng, R.; Yao, B.; Yu, H.; Wang, H.; Bian, J.; Feng, F. Novel family of antimicrobial peptides from the skin of Rana shuchinae. Peptides 2010, 31, 1674–1677. [Google Scholar] [CrossRef] [PubMed]
  79. Pei, J.; Zhao, G.; Wang, B.; Wang, H. Three novel antimicrobial peptides from the skin of Rana shuchinae. Gene 2013, 521, 234–237. [Google Scholar] [CrossRef] [PubMed]
  80. Wang, X.; Song, Y.; Li, J.; Liu, H.; Xu, X.; Lai, R.; Zhang, K. A new family of antimicrobial peptides from skin secretions of Rana pleuraden. Peptides 2009, 28, 2069–2074. [Google Scholar] [CrossRef]
  81. Abraham, P.; George, S.K.; Santhosh, K. Novel antibacterial peptides from the skin secretion of the Indian bicoloured frog Clinotarsus curtipes. Biochimie 2013, 97, 144–151. [Google Scholar] [CrossRef] [PubMed]
  82. Song, Y.; Lub, Y.; Wang, L.; Yang, H.; Zhang, K.; Lai, R. Purification, characterization and cloning of two novel tigerinin-like peptides from skin secretions of Fejervarya cancrivora. Peptides 2009, 30, 1228–1232. [Google Scholar] [CrossRef] [PubMed]
  83. Sai, K.P.; Jagannadham, M.V.; Vairamani, M.; Raju, N.P.; Devi, A.S.; Nagaraj, R.; Sitaram, N. Tigerinins: Novel antimicrobial peptides from the Indian frog Rana tigerina. J. Biol. Chem. 2001, 276, 2701–2707. [Google Scholar] [CrossRef] [PubMed]
  84. Ojo, O.O.; Abdel-Wahab, Y.H.A.; Flatt, P.R.; Mechkarska, M.; Conlon, J.M. Tigerinin-1R: A potent, non-toxic insulin-releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus. Diabetes Obe. Metab. 2011, 13, 1114–1122. [Google Scholar] [CrossRef]
  85. Srinivasan, D.; Ojo, O.O.; Abdel-Wahab, Y.H.A.; Flatt, P.R.; Guilhaudis, L.; Conlon, J.M. Insulin-releasing and cytotoxic properties of the frog skin peptide, tigerinin-1R: A structure-activity study. Peptides 2014, 55, 23–31. [Google Scholar] [CrossRef] [PubMed]
  86. Wei, L.; Dong, L.; Zhao, T.; You, D.; Liu, R.; Liu, H.; Yang, H.; Lai, R. Analgesic and anti-inflammatory effects of the amphibian neurotoxin, anntoxin. Biochimie 2011, 93, 995–1000. [Google Scholar] [CrossRef] [PubMed]
  87. Wu, Y.; Wang, L.; Zhou, M.; Ma, C.; Chen, X.; Bai, B.; Chen, T.; Shaw, C. Limnonectins: A new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis). Biochimie 2011, 93, 981–987. [Google Scholar] [CrossRef] [PubMed]
  88. Lu, Z.; Zhai, L.; Wang, H.; Che, Q.; Wang, D.; Feng, F.; Zhao, Z.; Yu, H. Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri. Biochimie 2010, 92, 475–481. [Google Scholar] [CrossRef] [PubMed]
  89. Meng, P.; Wei, L.; Yang, S.; Liu, H.; Liu, R.; Lai, R. A novel frog skin peptide containing function to induce muscle relaxation. Biochimie 2012, 94, 2508–2513. [Google Scholar] [CrossRef] [PubMed]
  90. Kawasaki, H.; Isaacson, T.; Iwamuro, S.; Conlon, J.M. A protein with antimicrobial activity in the skin of Schlegel’s green tree frog Rhacophorus schlegelii (Rhacophoridae) identified as histone H2B. Biochem. Biophys. Res. Commun. 2003, 312, 1082–1086. [Google Scholar] [CrossRef] [PubMed]
  91. Miao, Y.; Li, W.; Duan, L.; Xiao, Y. A bombesin-like peptide from skin of Sanguirana varians. Comp. Biochem. Physiol. 2010, 155, 106–109. [Google Scholar] [CrossRef]
  92. Ramesh, B.; Vadivelu, P.; Kavitha, K.; Suresh, G.; Ravichandran, N.; Siva, G.V. Antimicrobial peptide from Euphlyctis hexadactylus and its efficacy against plant pathogens. Int. J. Curr. Res 2010, 6, 14–17. [Google Scholar]

Share and Cite

MDPI and ACS Style

Kumar, V.T.V.; Holthausen, D.; Jacob, J.; George, S. Host Defense Peptides from Asian Frogs as Potential Clinical Therapies. Antibiotics 2015, 4, 136-159. https://doi.org/10.3390/antibiotics4020136

AMA Style

Kumar VTV, Holthausen D, Jacob J, George S. Host Defense Peptides from Asian Frogs as Potential Clinical Therapies. Antibiotics. 2015; 4(2):136-159. https://doi.org/10.3390/antibiotics4020136

Chicago/Turabian Style

Kumar, Vineeth T.V., David Holthausen, Joshy Jacob, and Sanil George. 2015. "Host Defense Peptides from Asian Frogs as Potential Clinical Therapies" Antibiotics 4, no. 2: 136-159. https://doi.org/10.3390/antibiotics4020136

APA Style

Kumar, V. T. V., Holthausen, D., Jacob, J., & George, S. (2015). Host Defense Peptides from Asian Frogs as Potential Clinical Therapies. Antibiotics, 4(2), 136-159. https://doi.org/10.3390/antibiotics4020136

Article Metrics

Back to TopTop